GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 89 filers reported holding GRITSTONE ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $119,422 | -12.1% | 69,431 | -0.3% | 0.00% | – |
| Q2 2023 | $135,823 | -30.2% | 69,647 | -0.5% | 0.00% | – |
| Q1 2023 | $194,592 | -17.9% | 69,999 | +1.8% | 0.00% | – |
| Q4 2022 | $237,135 | +31.7% | 68,733 | -1.8% | 0.00% | – |
| Q3 2022 | $180,000 | +25.0% | 69,987 | +17.7% | 0.00% | – |
| Q2 2022 | $144,000 | -43.8% | 59,471 | -4.3% | 0.00% | – |
| Q1 2022 | $256,000 | -69.1% | 62,128 | -3.6% | 0.00% | -100.0% |
| Q4 2021 | $829,000 | -6.7% | 64,478 | -21.6% | 0.00% | 0.0% |
| Q3 2021 | $889,000 | +50.2% | 82,288 | +27.0% | 0.00% | 0.0% |
| Q2 2021 | $592,000 | +73.1% | 64,799 | +78.5% | 0.00% | 0.0% |
| Q1 2021 | $342,000 | – | 36,299 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,450,638 | $17,536,000 | 1.82% |
| EcoR1 Capital, LLC | 3,421,287 | $13,480,000 | 0.72% |
| FRAZIER MANAGEMENT LLC | 2,061,758 | $8,123,000 | 0.63% |
| BVF INC/IL | 2,695,418 | $10,620,000 | 0.42% |
| Column Group LLC | 869,493 | $3,426,000 | 0.31% |
| Avidity Partners Management LP | 2,122,064 | $8,361,000 | 0.27% |
| Redmile Group, LLC | 3,059,794 | $12,056,000 | 0.15% |
| SkyOak Wealth, LLC | 69,778 | $275,000 | 0.09% |
| Tekla Capital Management LLC | 419,005 | $1,651,000 | 0.06% |
| Blackstone Inc. | 2,567,445 | $10,116,000 | 0.04% |